BioAmber is a sustainable chemicals company. Its technology platform combines industrial biotechnology and chemical catalysis to provide new chemicals. BioAmber’s goal is to be a leading provider of sustainable chemicals by replacing petroleum-based chemicals with renewable alternatives, which the Company believes could revolutionize the global chemical industry. 

Type
Public
HQ
Montréal, CA
Founded
2008
Size (employees)
86 (est)
BioAmber was founded in 2008 and is headquartered in Montréal, CA
Report incorrect company information

BioAmber Office Locations

BioAmber has offices in Montréal, Saint Paul and Sarnia
Montréal, CA (HQ)
1250 Boulevard René-Lévesque O
Sarnia, CA
1201 Vidal St S
Saint Paul, US
1000 Westgate Dr
Show all (3)
Report incorrect company information

BioAmber Financials and Metrics

BioAmber Financials

BioAmber's revenue was reported to be $2.17 m in FY, 2015 which is a 40.8% increase from the previous period.
USD

Net income (Q1, 2017)

(1.4 m)

EBIT (Q1, 2017)

(10.6 m)

Market capitalization (31-Oct-2017)

19.2 m

Closing share price (31-Oct-2017)

0.5

Cash (31-Mar-2017)

5.3 m
BioAmber's current market capitalization is $19.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.7 m1.5 m2.2 m

Revenue growth, %

(42%)41%

Sales and marketing expense

4.7 m4.5 m4 m2.9 m

General and administrative expense

9.8 m10.7 m10.6 m9.5 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

414.6 k469.3 k367.2 k1.5 m2.5 m

Sales and marketing expense

1.7 m954.2 k1.2 m1.1 m920.7 k1.2 m583.5 k479.4 k641.5 k

General and administrative expense

2.9 m2.4 m2.6 m3 m2.2 m2.6 m3 m1.8 m4.9 m

R&D expense

6 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

83.7 m7 m16.2 m

Accounts Receivable

755 k476.9 k978.6 k986.9 k

Inventories

2.4 m1.8 m1.7 m4.5 m

Current Assets

95 m57.1 m10.8 m31.4 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

48.7 m34.2 m14.1 m5.5 m15.9 m5.3 m

Accounts Receivable

406.6 k226.9 k1.4 m2.2 m4 m293.3 k

Inventories

1.3 m1.3 m2.2 m2.8 m2.5 m4.8 m

Current Assets

54.7 m38 m20.1 m11.9 m23.4 m20.8 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(33.8 m)(47.3 m)(41.2 m)(28.4 m)

Inventories

(521.1 k)1.2 m(8.1 k)(2.8 m)

Cash From Operating Activities

(27.5 m)(22.5 m)(32.2 m)(37.6 m)

Purchases of PP&E

(12.8 m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(14.1 m)(8.5 m)(9 m)(23.8 m)(32.3 m)(12.5 m)(9.6 m)(16.3 m)(1.4 m)

Inventories

(110.6 k)985.3 k(178.1 k)489 k494.4 k(346.4 k)(1 m)(738.8 k)(305.5 k)

Cash From Operating Activities

(3.1 m)(2.3 m)(5.9 m)(15.6 m)(22.5 m)(20.3 m)(25.7 m)(33.1 m)(10.6 m)

Purchases of PP&E

(20 m)
Show all financial metrics
Report incorrect company information

BioAmber Online and Social Media Presence

Embed Graph
Report incorrect company information

BioAmber News and Updates

BioAmber Receives Favourable Court Ruling and Approval for DIP Financing

MONTREAL, June 18, 2018 /PRNewswire/ - BioAmber Inc.  (OTCPK: BIOA) ("BioAmber") announced today that it has received formal Quebec court approval for debtor-in-possession (DIP) financing. This funding will enable the execution of the Sales and Investor Solicitation Process (SISP) that com...

BioAmber Receives Favourable Court Ruling and Approval for DIP Financing

MONTREAL, June 18, 2018 /PRNewswire/ - BioAmber Inc.  (OTCPK: BIOA) ("BioAmber") announced today that it has received formal Quebec court approval for debtor-in-possession (DIP) financing. This funding will enable the execution of the Sales and Investor Solicitation Process (SISP) that com...

BioAmber Receives Favourable Court Ruling and Approval for DIP Financing

MONTREAL, June 18, 2018 /PRNewswire/ - BioAmber Inc.  (OTCPK: BIOA) ("BioAmber") announced today that it has received formal Quebec court approval for debtor-in-possession (DIP) financing. This funding will enable the execution of the Sales and Investor Solicitation Process (SISP) that com...
Report incorrect company information